Product Reports Resources Pricing Login Book a demo

Slate Medicines

Biotech & Life Sciences · Raleigh, United States · Founded 2026

Anti-PACAP monoclonal antibody for migraine prevention MoreLess

Slate Medicines is a biotechnology company developing next-generation therapeutics targeting PACAP for the prevention and treatment of migraines and related headache disorders. The company focuses on injectable therapies, including monoclonal antibodies, with potential at-home administration. Led by experienced biopharma executives, Slate aims to advance innovative migraine treatments where previous approaches have struggled, leveraging licensed assets and proprietary research to build a pipeline of headache disorder therapies.

Keywords: migraine, headache, therapeutics, PACAP, monoclonal antibody, injectable, at-home dosing, biotech, clinical development, health

Valuation $500M–1B
Headcount <100
Total funding $100–500M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Slate Medicines and the history behind them.

Talent graph

Slate Medicines's talent

Book a demo to see the people
Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

3 investors on Slate Medicines's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series A 3 investors entered at this stage
Forbion Capital Partners
Foresite Capital
RA Capital Management

Global footprint

Where Slate Medicines has talent and traffic

Workforce by country
2 countries with
team presence
🇺🇸 United States75%
🇩🇪 Germany25%
2 countries shown

Market sentiment

What the market is saying about Slate Medicines

An AI-synthesized read of the highest-engagement posts about Slate Medicines on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Slate Medicines on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles